Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations

Slide collection

229,771-229,800 of 319,975

filter-aware
06
CG Oncology | IPO Presentation Deck | 45 slidesCG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank 1 hit
07
Uses a comparative diagram to illustrate the biological mechanism.CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Beat · Solution1 hit
08
The slide uses a circular process diagram overlaid on a cross-section of a bladder to explain the treatment steps.CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Beat · Solution1 hit
09
Uses a before-after framing to explain the mechanism of action for the DDM surfactant.CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Beat · Solution1 hit
10
The slide uses a biological process flow to explain the therapeutic mechanism.CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Beat · Solution1 hit
11
The slide uses a three-column layout to categorize the problem into prevalence, clinical challenges, and patient profile.CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Beat · ProblemLoop · Cost Of Inaction1 hit
12
The diagram shows the progression of tumor invasion through the bladder wall layers (Lamina Propria, Inner Muscle, Deep Muscle).CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Beat · Market SizeLoop · Cost Of Inaction1 hit
13
The slide uses a process flow that transitions into a decision tree/matrix based on risk levels.CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
14
The slide highlights the regulatory environment as a key driver for development, citing specific FDA definitions and successful approvals.CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
15
The slide uses a hierarchical tree structure to map clinical trials to specific patient segments (Intermediate vs High Risk, BCG-naïve/exposed/unresponsive).CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
16
Includes FDA Fast Track and Breakthrough Therapy designations.CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
17
BOND-003 study data.CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
18
Efficacy data cutoff as of October 5, 2023. Footnote indicates some patients excluded from 6-month assessment.CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Beat · TractionLoop · Cost Of Inaction1 hit
19
The slide uses a swimmer plot to visualize individual patient response durations, including complete response, recurrence, and reinduction events.CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Beat · TractionLoop · Cost Of Inaction1 hit
20
BOND-003 clinical trial safety data.CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
21
The slide explicitly notes that these are not head-to-head studies.CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
22
The slide uses a process-flow style layout to define the clinical trial parameters.CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
23
The slide uses a swimmer plot to visualize patient-level clinical trial data.CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
24
The table lists specific medical conditions (Preferred Terms) and their occurrence rates across 35 patients.CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
25
The slide uses a detailed comparison table to highlight the competitive positioning of CG Oncology's CORE-001 trial against other industry players.CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
26
PIVOT-006 trial design slide.CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
27
The slide uses a process-flow layout to define the clinical trial structure.CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
28
The slide uses a hierarchical tree structure to map patient risk categories to specific clinical trial programs (PIVOT-006, CORE-008, BOND-003, CORE-001).CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
29
CMC stands for Chemistry, Manufacturing, and Controls.CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
30
The slide uses a grid of four headshots with biographical details and company logos for each member.CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
31
The slide uses a circular process flow graphic to represent a sequential commercialization strategy.CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
32
The diagram uses a hub-and-spoke model to show how various commercial roles interact with the central customer entities (LUGPA and Hospitals).CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
33
The slide uses a grid-based timeline layout to map specific clinical trial milestones (stars) against time periods.CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
34
CG Oncology | IPO Presentation Deck | 45 slidesCG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
35
This is a standard contact/footer slide often found at the end of a pitch deck.CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Loop · Cost Of Inaction1 hit